Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cohen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|August 3, 2023
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumorsSarah E S Leary, Arzu Onar-Thomas, Jason Fangusaro, et al.
Therapeutic Innovation & Regulatory Science|May 16, 2018
Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master ProtocolsTahira Khan, Mark Stewart, Samuel Blackman, et al.
Cancer|October 13, 2007
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group studyMaryam Fouladi, H Stacy Nicholson, Tianni Zhou, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Neuro-Oncology|February 22, 2023
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908Ira J Dunkel, François Doz, Nicholas K Foreman, et al.
Blood|August 5, 2004
Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell functionAbie Craiu, Yoriko Saito, Ana Limon, et al.
Journal of Clinical and Translational Science|November 30, 2023
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2Nandini Avula, Dustin Kakach, Christopher J Tignanelli, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem InjuryDaphne Haas-Kogan, Daniel Indelicato, Harald Paganetti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|August 3, 2023
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumorsSarah E S Leary, Arzu Onar-Thomas, Jason Fangusaro, et al.
Therapeutic Innovation & Regulatory Science|May 16, 2018
Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master ProtocolsTahira Khan, Mark Stewart, Samuel Blackman, et al.
Cancer|October 13, 2007
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group studyMaryam Fouladi, H Stacy Nicholson, Tianni Zhou, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Neuro-Oncology|February 22, 2023
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908Ira J Dunkel, François Doz, Nicholas K Foreman, et al.
Blood|August 5, 2004
Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell functionAbie Craiu, Yoriko Saito, Ana Limon, et al.
Journal of Clinical and Translational Science|November 30, 2023
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2Nandini Avula, Dustin Kakach, Christopher J Tignanelli, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem InjuryDaphne Haas-Kogan, Daniel Indelicato, Harald Paganetti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.
Pageof 5